🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/12/1973 0,0093 USD
31/08/1973 0,0078 USD
05/06/1973 0,0078 USD
05/03/1973 0,0078 USD
05/12/1972 0,0078 USD
09/06/1972 0,0073 USD
02/03/1972 0,0073 USD
06/12/1971 0,0073 USD
03/09/1971 0,0073 USD
07/06/1971 0,0073 USD
02/03/1971 0,0073 USD
01/12/1970 0,0073 USD
02/09/1970 0,0066 USD
02/06/1970 0,0066 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/06/2018 59,90 59,98 59,24 59,48 -0,40% 1,24% 7.542.666
08/06/2018 59,17 59,78 59,13 59,71 +0,95% 1,10% 10.142.754
07/06/2018 59,16 59,20 58,69 59,15 +0,10% 0,85% 7.910.933
06/06/2018 58,69 59,10 58,42 59,09 +0,88% 1,17% 7.912.190
05/06/2018 59,16 59,48 58,26 58,58 -1,02% 2,05% 13.098.218
04/06/2018 58,73 59,67 58,38 59,18 +2,41% 2,19% 20.410.534
01/06/2018 57,15 58,02 56,89 57,79 +1,73% 1,99% 11.556.925
31/05/2018 56,90 57,14 56,59 56,80 -0,32% 0,96% 12.786.019
30/05/2018 55,96 57,06 55,84 56,98 +2,26% 2,18% 11.572.016
29/05/2018 55,90 56,19 55,37 55,73 -1,17% 1,47% 9.228.269
25/05/2018 56,43 56,74 56,15 56,38 -0,07% 1,05% 6.985.339
24/05/2018 56,54 56,69 56,12 56,42 -0,07% 1,01% 7.261.382
23/05/2018 55,77 56,77 55,75 56,46 +1,23% 1,81% 10.375.619
22/05/2018 56,09 56,43 55,73 55,77 -0,20% 1,26% 9.357.068
21/05/2018 56,47 56,60 55,72 55,89 -0,96% 1,57% 8.882.219
18/05/2018 56,26 56,74 54,86 56,43 +0,12% 3,34% 10.151.242
17/05/2018 56,81 57,04 56,18 56,36 -1,14% 1,51% 8.222.398
16/05/2018 56,60 57,26 56,40 57,01 +0,93% 1,52% 8.941.222
15/05/2018 56,72 57,06 56,20 56,49 -0,80% 1,51% 7.148.932
14/05/2018 57,03 57,33 56,71 56,95 -0,02% 1,09% 9.942.062
11/05/2018 55,50 57,22 55,47 56,96 +2,81% 3,16% 13.344.498
10/05/2018 55,47 56,04 55,28 55,40 +0,19% 1,38% 8.624.097
09/05/2018 54,36 55,73 54,23 55,30 +2,10% 2,77% 8.684.042
08/05/2018 54,74 54,79 53,68 54,16 -1,08% 2,02% 10.749.546
07/05/2018 55,12 55,44 54,47 54,75 -0,64% 1,77% 10.513.955
04/05/2018 54,50 55,26 54,23 55,11 +0,38% 1,89% 9.149.983
03/05/2018 54,52 55,15 53,79 54,90 +0,40% 2,50% 11.864.932
02/05/2018 55,04 55,34 54,41 54,68 -1,17% 1,70% 10.921.837
01/05/2018 56,30 56,53 54,27 55,32 -1,51% 4,00% 13.756.782
30/04/2018 56,92 57,23 56,17 56,17 -1,01% 1,86% 13.730.267